You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: December 5, 2020

DrugPatentWatch Database Preview

Patent: 9,408,864

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,408,864
Title:Composition for regenerating normal tissue from fibrotic tissue
Abstract: The present invention relates to a pharmaceutical composition and a method for regenerating normal tissue from fibrotic tissue, the pharmaceutical composition and the method employing a collagen-reducing substance. In accordance with the present invention, normal tissue can be therapeutically regenerated from fibrotic tissue.
Inventor(s): Niitsu; Yoshiro (Sapporo, JP), Yoneda; Akihiro (Sapporo, JP), Ishiwatari; Hirotoshi (Sapporo, JP)
Assignee: Nitto Denko Corporation (Osaka, JP)
Application Number:13/813,907
Patent Claims:see list of patent claims

Details for Patent 9,408,864

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Smith And Nephew SANTYL collagenase OINTMENT;TOPICAL 101995 001 1965-06-04   Start Trial Nitto Denko Corporation (Osaka, JP) 2030-08-05 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 9,408,864

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 2006068232   Start Trial
World Intellectual Property Organization (WIPO) 2008120815   Start Trial
World Intellectual Property Organization (WIPO) 2009116257   Start Trial
World Intellectual Property Organization (WIPO) 2010026766   Start Trial
World Intellectual Property Organization (WIPO) 2011158933   Start Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.